President, Vaccines & Global Health
Roger Connor - download image from Flickr (JPG)
Roger was appointed President of GSK Vaccines in 2018. In addition to leadership of the Vaccines business, he has also led GSK’s Global Health organization since 2021, and is responsible for the global procurement organisation. He has been a Member of the Corporate Executive Team since 2013.
Skills and experience
Roger has deep and broad experience in the pharmaceutical industry. He has held a number of roles in finance, corporate strategy and manufacturing, most recently running GSK’s global pharmaceutical and consumer healthcare manufacturing organisation from 2013 to 2018. In this role he managed 75 sites across more than 30 countries, and was accountable for the leadership of 33,000 employees. Roger holds a degree in Mechanical and Manufacturing Engineering from Queen’s University, Belfast and a Master’s in Manufacturing Leadership from Cambridge University. He is a Chartered Accountant.
- Member of the Board of Gavi, the Vaccine Alliance
- Chair of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) CEO Vaccines Committee
Find out more
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Discover our latest financial performance announcement and search for historical quarterly results materials
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business